Cas:68123-33-1 N-Succinimidyl p-nitrophenylacetate manufacturer & supplier

We serve Chemical Name:N-Succinimidyl p-nitrophenylacetate CAS:68123-33-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Succinimidyl p-nitrophenylacetate

Chemical Name:N-Succinimidyl p-nitrophenylacetate
CAS.NO:68123-33-1
Synonyms:2,5-Pyrrolidinedione, 1-(((4-nitrophenyl)acetyl)oxy)-;1-[2-(4-Nitrophenyl)acetoxy]pyrrolidine-2,5-dione;(2,5-dioxopyrrolidin-1-yl) 2-(4-nitrophenyl)acetate;2,5-Pyrrolidinedione, 1-[[2-(4-nitrophenyl)acetyl]oxy]-;1-[2-(4-Nitrophenyl)acetoxy]-2,5-pyrrolidinedione;N-Succinimidyl p-nitrophenylacetate
Molecular Formula:C12H10N2O6
Molecular Weight:278.218
HS Code:2925190090

Physical and Chemical Properties:
Melting point:181ºC
Boiling point:463.6±47.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.613
PSA:109.50000
Exact Mass:278.053894
LogP:-0.30

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,5-Pyrrolidinedione, 1-(((4-nitrophenyl)acetyl)oxy)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Succinimidyl p-nitrophenylacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[2-(4-Nitrophenyl)acetoxy]-2,5-pyrrolidinedione Use and application,2,5-Pyrrolidinedione, 1-(((4-nitrophenyl)acetyl)oxy)- technical grade,usp/ep/jp grade.


Related News: Except current data is insufficient to determine its benefit in patients who are negative for anti-AChR antibodies. 1,2,2,5,5-pentamethyl-4-formyl-3-imidazolin-3-oxide manufacturers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 5-chloro-N-phenyl-1,2,3-thiadiazole-4-carboxamide suppliers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. 4-(3-chlorophenyl)-6-((4-chlorophenyl)(1,2-dimethyl-1H-imidazol-5-yl)(hydroxy)methyl)-1-methylquinolin-2(1H)-one vendor & factory.